033270.KS · 유나이티드제약
South Korea · RS rating 50 · As of 2026-10-14
| Price | 17,430.00 KRW |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 36 / 49 / 54 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 30 / 45 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +171.3% |
| Sales growth Q/Q | +4.6% |
| Distance from 52-week high | +18.6% |
| Market cap (USD) | $211.0M |